NYSE: $NVO A Breakthrough in Insulin Therapy Managing type 1 and type 2 diabetes has long required the demanding routine of daily insulin injections. However, a significant advancement has arrived. The FDA has officially approved Awiqli (insulin icodec), marking it as the first and only once-weekly basal insulin for children and adolescents aged 10 years…